title: The rationale behind hypofractionated high-dose intensity-modulated radiotherapy in patients with localized prostate cancer: short review.
abstract: The use of improved technology has fostered increasing interest in hypofractionated radiation therapy for prostate cancer. There also is convincing evidence that an unusual aspect of prostate cancer radiobiology allow a different approach to dose escalation that is radiobiological in nature. The aim of this paper is to explain the rationale behind hypofractionated high-dose intensity-modulated radiotherapy in patients with localized prostate cancer.
authors.affiliation: Paediatric Department, Royal Berkshire NHS Foundation Trust. London Road, Reading RG1 5AN, UK.
authors.forename: Elwira
authors.initials: E
authors.lastname: Szychot
authors.forename: Andrzej
authors.initials: A
authors.lastname: Brodkiewicz
authors.forename: Jarosław
authors.initials: J
authors.lastname: Peregud-Pogorzelski
mesh_terms: D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D011879:Radiotherapy Dosage; D050397:Radiotherapy, Intensity-Modulated